108 related articles for article (PubMed ID: 8863516)
1. Amyloid beta toxicity consists of a Ca(2+)-independent early phase and a Ca(2+)-dependent late phase.
Abe K; Kimura H
J Neurochem; 1996 Nov; 67(5):2074-8. PubMed ID: 8863516
[TBL] [Abstract][Full Text] [Related]
2. Reduction of beta-amyloid-induced neurotoxicity on hippocampal cell cultures by moderate acidosis is mediated by transforming growth factor beta.
Uribe-San Martín R; Herrera-Molina R; Olavarría L; Ramírez G; von Bernhardi R
Neuroscience; 2009 Feb; 158(4):1338-47. PubMed ID: 19041694
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of free radical formation fail to attenuate direct beta-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures.
Lockhart BP; Benicourt C; Junien JL; Privat A
J Neurosci Res; 1994 Nov; 39(4):494-505. PubMed ID: 7533847
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of neurotoxicity of alzheimer's amyloid beta protein (beta42) in cultured hippocampal cells and its prevention by propentofylline.
Koriyama Y; Yamazaki M; Chiba K; Mohri T
Jpn J Pharmacol; 2000 Apr; 82(4):301-6. PubMed ID: 10875749
[TBL] [Abstract][Full Text] [Related]
5. Amyloid beta protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes.
Abe K; Saito H
Neurosci Res; 1998 Aug; 31(4):295-305. PubMed ID: 9809588
[TBL] [Abstract][Full Text] [Related]
6. Estradiol attenuation of beta-amyloid-induced toxicity: a comparison o.
Green PS; Perez EJ; Calloway T; Simpkins JW
J Neurocytol; 2000; 29(5-6):419-23. PubMed ID: 11424958
[TBL] [Abstract][Full Text] [Related]
7. Steroid hormones block amyloid fibril-induced 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis: relationship to neurotoxicity.
Liu Y; Schubert D
J Neurochem; 1998 Dec; 71(6):2322-9. PubMed ID: 9832130
[TBL] [Abstract][Full Text] [Related]
8. Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT.
Abe K; Matsuki N
Neurosci Res; 2000 Dec; 38(4):325-9. PubMed ID: 11164558
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.
Liu Y; Schubert D
J Neurochem; 1997 Dec; 69(6):2285-93. PubMed ID: 9375659
[TBL] [Abstract][Full Text] [Related]
10. A novel compound RS-0466 reverses beta-amyloid-induced cytotoxicity through the Akt signaling pathway in vitro.
Nakagami Y; Nishimura S; Murasugi T; Kubo T; Kaneko I; Meguro M; Marumoto S; Kogen H; Koyama K; Oda T
Eur J Pharmacol; 2002 Dec; 457(1):11-7. PubMed ID: 12460638
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.
Barger SW; Hörster D; Furukawa K; Goodman Y; Krieglstein J; Mattson MP
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9328-32. PubMed ID: 7568127
[TBL] [Abstract][Full Text] [Related]
12. A novel method for the rapid determination of beta-amyloid toxicity on acute hippocampal slices using MTT and LDH assays.
Mozes E; Hunya A; Posa A; Penke B; Datki Z
Brain Res Bull; 2012 Apr; 87(6):521-5. PubMed ID: 22387609
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxicity of a carboxyl-terminal fragment of the Alzheimer's amyloid precursor protein.
Kim SH; Suh YH
J Neurochem; 1996 Sep; 67(3):1172-82. PubMed ID: 8752124
[TBL] [Abstract][Full Text] [Related]
14. Antioxidants prevent amyloid peptide-induced apoptosis and alteration of calcium homeostasis in cultured cortical neurons.
Huang HM; Ou HC; Hsieh SJ
Life Sci; 2000 Mar; 66(19):1879-92. PubMed ID: 10809185
[TBL] [Abstract][Full Text] [Related]
15. Both oxidative stress-dependent and independent effects of amyloid beta protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction assay.
Abe K; Saito H
Brain Res; 1999 May; 830(1):146-54. PubMed ID: 10350568
[TBL] [Abstract][Full Text] [Related]
16. Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells.
Pollack SJ; Sadler II; Hawtin SR; Tailor VJ; Shearman MS
Neurosci Lett; 1995 Jan; 184(2):113-6. PubMed ID: 7724043
[TBL] [Abstract][Full Text] [Related]
17. Cellular MTT reduction distinguishes the mechanism of action of beta-amyloid from that of tachykinin receptor peptides.
Shearman MS
Neuropeptides; 1996 Apr; 30(2):125-32. PubMed ID: 8771554
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization.
Pike CJ; Balázs R; Cotman CW
J Neurochem; 1996 Oct; 67(4):1774-7. PubMed ID: 8858966
[TBL] [Abstract][Full Text] [Related]
19. Nicotine attenuates beta-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures.
Liu Q; Zhao B
Br J Pharmacol; 2004 Feb; 141(4):746-54. PubMed ID: 14757701
[TBL] [Abstract][Full Text] [Related]
20. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.
Shearman MS; Hawtin SR; Tailor VJ
J Neurochem; 1995 Jul; 65(1):218-27. PubMed ID: 7790863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
